Full-Time
Staff Systems Engineer
Posted on 3/5/2025
Mendaera
51-200 employees
Delivers point-of-care medical devices
Compensation Overview
$175k - $211k/yr
San Mateo, CA, USA
In Person
 Biology & Biotech (2) |
|---|
| , |
- Lead cross-functional teams to design and develop complex medical devices
- Understand the system from both a technical and user perspective, and drive definition and development of the system accordingly
- Work with product to translate clinical and business requirements to design input requirements and technical specifications
- Generate use cases, trade studies, and risk assessments to facilitate systematic trade-off decisions and robust engineering solutions
- Develop test methods to accurately characterize and verify the system design against performance requirements
- Build prototypes, fixtures, and scripts for data acquisition and analysis
- Work cross-disciplinarily to provide hands-on system troubleshooting and debugging
- Prioritize engineering feature sets and drive system level execution
- Entrepreneurial, self-motivated, and independent
- Excellent technical and analytical capability
- High emotional intelligence and ability to build and manage diverse relationships
- Significant demonstrated experience collaborating with technical partners
- Strong written and verbal communication skills; exceptional presentation skills
- Versatility and ability to operate in a small-team environment
- Excellent technical and analytical capability
- Medical-device product development experience, including verification and validation
- Advanced technical degree and ≥5 years industry experience preferred
Mendaera provides medical devices and healthcare technology designed to support clinicians at the point of care. Its solutions help doctors and nurses perform procedures with higher precision and consistency directly where patients receive treatment, aiming to streamline care and improve outcomes. The devices integrate into the care workflow to reduce unnecessary patient movement, speed recovery, and lower overall costs. Revenue comes from selling these technologies to hospitals, clinics, and individual practitioners, with engagement also involving administrators and payors to align value and reimbursement. The company adheres to regulatory standards to ensure safety and effectiveness, partnering with regulators and stakeholders to bring compliant technologies to market. Overall, Mendaera’s goal is to improve patient outcomes, boost patient satisfaction, and reduce the cost of care by making medical interventions more efficient at the point of care.
Company Size
51-200
Company Stage
Series B
Total Funding
$97M
Headquarters
San Carlos, California
Founded
2020
Simplify's Take
What believers are saying
- First procedures completed September 2025; full commercialization launch planned for 2026.
- Expanding from urology to multiple specialties addresses hundreds of millions of annual procedures.
- Healthcare provider workforce shortages create urgent demand for precision automation at point-of-care.
What critics are saying
- Intuitive Surgical dominates surgical robotics; could extend into handheld interventions and block Mendaera.
- Reimbursement payers may classify Focalist as incremental improvement, capping pricing power.
- Limited early adoption or complications in urology cases delay 2026 commercialization and market confidence.
What makes Mendaera unique
- Focalist combines handheld robotics with real-time ultrasound imaging for precise needle placement.
- FDA-cleared system addresses clinical skill variability requiring years of training to master.
- Partnerships with Cook Medical and EchoNous integrate market-leading needles and portable ultrasound.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Professional Development Budget
Growth & Insights and Company News
6 month growth
↑ 3%1 year growth
↑ 0%2 year growth
↑ 5%Mendaera, a healthcare robotics firm, secured $73 million in Series B funding, following a $24 million Series A led by Lux Capital in 2023. The funds will help scale their robotic and AI technologies for medical procedures like biopsies and organ access. Mendaera is expanding partnerships, including with Cook Medical and EchoNous, to enhance needle-based interventions. They also acquired Avail Medsystems' telepresence tech to improve patient access and care delivery.
Cook Medical collaborates with Mendaera(TM) to advance needle-based intervention with handheld robotics.
Mendaera appoints medical robotics leader Eric Davidson as Chief Commercial Officer.
Mendaera has secured $73M in venture capital to advance its handheld robotics platform for needle-based procedures like biopsy and vascular access. The Silicon Valley startup aims to address healthcare provider shortages and rising demand by integrating real-time imaging with robotic guidance. The Series B funding was led by Threshold Ventures, with participation from Lux Capital and others, to enhance patient care and expand access to high-quality medical procedures.
Portable ultrasound company EchoNous and AI and robotics company Mendaera have established a commercial partnership to develop new ultrasound-guided technology for interventional procedures.